Organigram receives Nasdaq minimum bid price deficiency notice, with compliance deadline of May 2027
The Canadian cannabis company says its shares closed below US$1.00 for 30 consecutive business days. The notice does not affect trading on Nasdaq or the TSX.
Organigram Global, a Canadian cannabis company, has disclosed that Nasdaq notified it on 11 November 2026 that it fails the exchange's minimum bid price requirement. Its shares closed below US$1.00 for 30 consecutive business days, which breaches Nasdaq Listing Rule 5450(a)(1).
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Company's press release (SEC filing): Organigram Global Inc. ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.